Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Plasmocin® - Mycoplasma Elimination Reagent Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the sti... 2022 J Exp Clin Cancer Res. Rigiracciolo D.C. et al. DOI: 10.1186/s13046-022-02396-0
ODN 1668 - TLR9 ligand ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides... 2022 J Lipid Res. Deng M. et al. DOI: 10.1016/j.jlr.2022.100237
TDB Mincle-binding DNA aptamer demonstrates therapeutic potential in a model of i... 2022 Mol Ther Nucleic Acids Stephens M. et al. DOI: 10.1016/j.omtn.2022.05.026
Anti-mouse Mincle (CLEC4E) antibody Mincle-binding DNA aptamer demonstrates therapeutic potential in a model of i... 2022 Mol Ther Nucleic Acids Stephens M. et al. DOI: 10.1016/j.omtn.2022.05.026
Blasticidin Therapeutical Significance of Serpina3n Subsequent Cerebral Ischemia via Cyto... 2022 Biomed Res Int. Aslam M.S. et al. DOI: 10.1155/2022/1557010
Puromycin Therapeutical Significance of Serpina3n Subsequent Cerebral Ischemia via Cyto... 2022 Biomed Res Int. Aslam M.S. et al. DOI: 10.1155/2022/1557010
EndoFit™ OVA protein Antigen bivalency of antigen-presenting cell-targeted vaccines increases B ce... 2022 Cell Rep. Hinke D.M. et al. DOI: 10.1016/j.celrep.2022.110901
AddaVax™ Antigen bivalency of antigen-presenting cell-targeted vaccines increases B ce... 2022 Cell Rep. Hinke D.M. et al. DOI: 10.1016/j.celrep.2022.110901
OVA peptides Antigen bivalency of antigen-presenting cell-targeted vaccines increases B ce... 2022 Cell Rep. Hinke D.M. et al. DOI: 10.1016/j.celrep.2022.110901
ODN TTAGGG (A151) Neutrophil extracellular traps mediate m6A modification and regulates sepsis-... 2022 Int J Biol Sci. Zhang H. et al. DOI: 10.7150/ijbs.69141
ODN 2395 - TLR9 ligand DNA Origami Nanostructures Elicit Dose-Dependent Immunogenicity and Are Nonto... 2022 Small Lucas C.R. et al. DOI: 10.1002/smll.202108063
Pam3CSK4 Decreased leukocyte exhaustion is associated with decreased IFN-β and increas... 2022 Cytokine Shruthi S. et al. DOI: 10.1016/j.cyto.2022.155918
THP1-Null Cells Rapid Hypothesis Testing in Candida albicans Clinical Isolates Using a Clonin... 2022 Microbiol Spectr. Liu J. et al. DOI: 10.1128/spectrum.02630-21
PMA - Phorbol myristate acetate Rapid Hypothesis Testing in Candida albicans Clinical Isolates Using a Clonin... 2022 Microbiol Spectr. Liu J. et al. DOI: 10.1128/spectrum.02630-21
CR3022-derived Anti-SARS-CoV2 RBD mAbs, human & mouse isotypes Ultrasensitive detection of salivary SARS-CoV-2 IgG antibodies in individuals... 2022 Sci Rep. Thomas S.N. et al. DOI: 10.1038/s41598-022-12869-z
Primocin® The unfolded protein response to PI*Z alpha-1 antitrypsin in human hepatocell... 2022 Hepatol Commun. Lu Y. et al. DOI: 10.1002/hep4.1997
LPS-EB VacciGrade™ The unfolded protein response to PI*Z alpha-1 antitrypsin in human hepatocell... 2022 Hepatol Commun. Lu Y. et al. DOI: 10.1002/hep4.1997
Nigericin NLRP3 licenses NLRP11 for inflammasome activation in human macrophages. 2022 Nat Immunol. Gangopadhyay A. et al. DOI: 10.1038/s41590-022-01220-3
FSL-1 NLRP3 licenses NLRP11 for inflammasome activation in human macrophages. 2022 Nat Immunol. Gangopadhyay A. et al. DOI: 10.1038/s41590-022-01220-3
Pam3CSK4 NLRP3 licenses NLRP11 for inflammasome activation in human macrophages. 2022 Nat Immunol. Gangopadhyay A. et al. DOI: 10.1038/s41590-022-01220-3

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty